Navigate FDA Compliance with Certainty
Hands-on regulatory strategy, quality system design, and FDA inspection readiness for medical device and IVD companies.
The Full Spectrum of FDA Regulatory & Quality Consulting
Every engagement draws on deep, hands-on experience across regulatory affairs, quality systems, and compliance — built specifically for FDA-regulated companies.
Regulatory Affairs
- FDA Regulatory Strategy & Pathway Analysis
- 510(k) / De Novo / PMA Submissions
- Labeling Review & Change Assessments
- Post-Market Compliance & Surveillance
Quality Systems
- QMS Design, Implementation & Improvement
- ISO 13485 & MDSAP Readiness
- Process & Software Validation
- Change Control Management
Compliance & Enforcement
- FDA Inspection Readiness & Mock Inspections
- 483 Observation & Warning Letter Response
- Compliance Remediation Programs
- Internal & Supplier Audit Programs
Ongoing Advisory
- Fractional QA/RA Support
- Regulatory Due Diligence
- Quality System Assessments & Gap Analysis
- Expert Review & Technical Writing
The Difference Senior
Experience Makes
Senior-Level Judgment, Not Junior Staff
Your project is led by consultants with decades of direct FDA regulatory and quality experience — not delegated to entry-level associates.
Practical Execution, Not Just Advice
We work alongside your team to build, fix, and improve — not just produce reports that sit on a shelf.
Deep Medical Device & IVD Focus
Our entire practice is focused on FDA-regulated medical devices and diagnostics. We understand the nuances that generalists miss.
Risk-Based, Business-Aware Approach
We align regulatory strategy with your commercial timeline, funding stage, and operational reality.
Inspection-Tested Methods
Our quality systems and compliance frameworks are built from real-world FDA inspection experience — not academic theory.
Responsive and Straightforward
No opaque processes or unnecessary overhead. Direct communication, clear deliverables, and practical timelines.
A Structured Engagement. Every Time.
Our process is consistent by design — not improvised. Every engagement follows the same disciplined path from initial assessment to sustained compliance readiness.
Situational Review
- Quality system & documentation review
- Regulatory history & gap analysis
- Risk identification & priority mapping
Define the Work
- Defined deliverables & acceptance criteria
- Milestone-based project structure
- Resource & timeline alignment
Hands-On Implementation
- Direct involvement in deliverable creation
- Ongoing status reporting & communication
- Issue identification & resolution
Records & Work Products
- Audit-ready documentation packages
- SOPs, CAPAs & formal work products
- Regulatory submission support
Readiness & Continuity
- Internal team knowledge transfer
- Ongoing monitoring frameworks
- Optional fractional advisory support
Engagements are scoped to match your specific situation — not templated. Timeline and depth vary based on your current state, regulatory objectives, and resource constraints.
The Right Experience for Your Stage
Startups & First-Time Manufacturers
Companies navigating device classification, pathway selection, and first-time QMS build — before their first FDA submission.
Investor & PE-Backed Ventures
Portfolio companies requiring regulatory due diligence, QA/RA structuring, and clear compliance roadmaps ahead of growth milestones.
Growth-Stage Manufacturers
Companies expanding production, adding product lines, or entering new markets — and building the compliance infrastructure to support it.
IVD & Diagnostics Companies
Developers managing FDA requirements for lab instruments, point-of-care platforms, assay submissions, and 510(k) clearances.
Medical Device Manufacturers
Class I through Class III manufacturers managing complex QMS environments, remediation workloads, and ongoing inspection readiness.
Global & Multi-Site Organizations
Companies managing MDSAP programs, multi-site quality systems, notified body relationships, and post-market obligations at scale.
Engagements That Move the Needle
Class II Medical Device Manufacturer Prepares for First FDA Inspection
We conducted a comprehensive pre-inspection audit, identified high-risk areas, and developed a detailed remediation plan. The FDA inspection resulted in zero 483 observations, and the manufacturer gained confidence in their quality systems.
Established Manufacturer Resolves Multiple 483 Observations
Following an FDA inspection with six observations, we led root cause analysis, developed comprehensive corrective actions, and prepared a detailed response. FDA accepted the response without further action.
IVD Startup Implements ISO 13485-Compliant QMS
We designed and implemented a scalable ISO 13485-compliant QMS tailored to their stage and resources. The company successfully submitted their 510(k) with complete documentation and received FDA clearance.
Specific client names, quantified outcomes, and detailed engagement descriptions have been kept confidential at the clients request.
What Our Clients Say
"FDA RA Group helped us navigate a complex 510(k) submission that two other consultants had struggled with. Their deep FDA experience and clear communication made all the difference. We received clearance ahead of schedule."
VP of Regulatory Affairs
Medical Device Manufacturer, TX
Ready to Strengthen Your Regulatory Position?
Let's Talk Future
Prefer to Schedule Directly?
Coming Soon